71.19
Finanzdaten der Ionis Pharmaceuticals Inc-Aktie (IONS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
29.74%
203.33
|
156.72 | 452.05 | 131.61 | 226.58 |
| Cost Of Revenue |
240.33%
7.957
|
2.338 | 4.151 | 1.463 | 3.83 |
| Gross Profit |
26.55%
195.37
|
154.38 | 447.90 | 130.15 | 222.75 |
| Operating Expenses |
32.82%
417.79
|
314.56 | 308.08 | 277.01 | 337.40 |
| Interest Income/Expense |
14.62%
4.828
|
4.212 | 4.114 | 4.108 | 4.191 |
| Benefits Costs and Expenses |
46.54%
417.79
|
285.11 | 328.52 | 278.43 | 337.40 |
| Costs And Expenses |
31.84%
417.79
|
316.90 | 312.23 | 278.47 | 337.40 |
| Operating Income/Loss |
33.88%
-214.46
|
-160.18 | 139.82 | -146.86 | -110.82 |
| Income/Loss From Continuing Operations Before Tax |
67.03%
-214.46
|
-128.39 | 123.53 | -146.82 | -110.82 |
| Income Tax Expense/Benefit |
593.90%
1.478
|
0.213 | -0.02 | 0.116 | -2.69 |
| Income/Loss From Continuing Operations After Tax |
78.37%
-229.39
|
-128.61 | 123.55 | -146.94 | -104.35 |
|
|
78.37%
-229.39
|
-128.61 | 123.55 | -146.94 | -104.35 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
100.39%
-0.628
|
159.76 | 159.14 | 158.74 | 2.811 |
| Diluted Average Shares |
85.88%
22.57
|
159.76 | 182.33 | 158.74 | 2.811 |
| Basic Earnings Per Share |
76.25%
-1.41
|
-0.80 | 0.78 | -0.93 | -0.66 |
| Diluted Earnings Per Share |
76.25%
-1.41
|
-0.80 | 0.70 | -0.93 | -0.66 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):